Novel colloidal carriers for psoriasis: Current issues, mechanistic insight and novel delivery approaches

Design, characterization and skin permeating potential of Fluocinolone acetonide loaded nanostructured lipid carriers for topical treatment of psoriasis

“…Psoriasis is a T cell mediated autoimmune, inflammatory skin disorder differentiated by red, scaly and raised patches [1]. In psoriasis, erratic remissions and reversions occur for a lifelong period.…”

Evaluation of transdermal salidroside delivery using niosomes via in vitro cellular uptake

“…Nonionic surfactants serve as transdermal enhancers that also increase cutaneous drug absorption (Nitin et al, 2013), besides Chol is present in the cell membrane and is relatively enriched in the skin, which may enhance absorption through the skin surface and fusion with the SC, and promote drug release from the niosomes, thereby increasing accelerating SAL diffusion into the hydrophilic dermal layer, consequently boosting drug penetration across skin (Pradhan et al, 2013). The results of their application to this study are shown in Fig.…”

Psoriasis: implication to disease and therapeutic strategies, with an emphasis on drug delivery approaches

“…The concerns of the transdermal drug delivery into the psoriasis lesional skin have recently been tackled by the novel carrier systems, such as transferosome, liposomes, niosome, ethosomes, microneedle, nanoemulsion, and cerosome, etc. The colloidal system resolves the problem of penetration to the stratum corneum barrier and also restores the normal skin conditions . Different nanocarrier‐based systems for delivery of drugs used in psoriasis treatment are listed in Table .…”